...
首页> 外文期刊>RSC Advances >Influence of ionic strength on the interaction of THA and its Cu(II) complex with DNA helps to explain studies on various breast cancer cells
【24h】

Influence of ionic strength on the interaction of THA and its Cu(II) complex with DNA helps to explain studies on various breast cancer cells

机译:离子强度对THA及其Cu(II)配合物与DNA相互作用的影响有助于解释对各种乳腺癌细胞的研究

获取原文
获取原文并翻译 | 示例

摘要

THA, a structural analogue of the family of anthracycline anticancer drugs, was used to understand how environmental changes affect its biophysical interactions with DNA. A variation of the ionic strength of the medium was attempted at a constant pH. Under such varying conditions, the binding constant and the site size of interaction were evaluated. Owing to the close structural similarity with anthracyclines and the fact that the quinone moiety in these drugs control the chemical reactions, the effect of the ionic strength on the physicochemical and biophysical attributes of hydroxy-9,10-anthraquinones is important. With an increase in ionic strength, the dissociation of the first proton of THA is affected to a greater extent compared to the second proton. Since the pK(a1) is connected to the generation of the mono-anion of THA, an increase in its value implies that there would be less anion in the medium leading to improved DNA binding. Increased NaCl concentration neutralizes the negative charges on the DNA backbone manifesting in an overall increase in the binding constant for THA. This fact might be exploited for the use of such molecules in cancer patients. However, in the case of a Cu-II complex of THA and the formation of anions being almost negligible, there is a marked improvement in DNA binding. The cytotoxic action of THA (LH3) and its Cu-II complex [Cu-II(LH2)(2)] was also studied on three breast carcinoma cell lines and a primary human dermal fibroblast cell line. The complex was seen to perform better than THA. The results could be explained with the help of the comet assay, the gamma H2AX foci assay, and DAPI staining followed by western blotting with an apoptotic protein marker. The findings of THA and its Cu-II complex were compared to anthracycline doxorubicin.
机译:THA是蒽环类抗癌药物家族的结构类似物,用于了解环境变化如何影响其与DNA的生物物理相互作用。尝试在恒定的pH下改变介质的离子强度。在这种变化的条件下,评估了结合常数和相互作用的位点大小。由于与蒽环类化合物的结构相似,并且这些药物中的醌部分控制化学反应,因此离子强度对羟基-9,10-蒽醌的物理化学和生物物理特性的影响非常重要。随着离子强度的增加,THA的第一个质子的离解比第二个质子受到更大的影响。由于pK(a1)与THA单阴离子的生成有关,因此其值的增加意味着培养基中阴离子的减少会导致DNA结合的改善。增加的NaCl浓度会中和DNA骨架上的负电荷,从而显示THA的结合常数整体增加。这一事实可被用于在癌症患者中使用此类分子。但是,在THA的Cu-II配合物和几乎没有阴离子形成的情况下,DNA结合显着改善。还研究了THA(LH3)及其Cu-II复合物[Cu-II(LH2)(2)]对三种乳腺癌细胞系和人类原代皮肤成纤维细胞系的细胞毒作用。该复合物的性能优于THA。可以通过彗星试验,伽玛H2AX病灶试验和DAPI染色,然后用凋亡蛋白标记进行Western印迹来解释结果。将THA及其Cu-II复合物的发现与蒽环类药物阿霉素进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号